Articles

Bausch & Lomb has received new technology intraocular lens (NTIOL) status for the regular and violet-filtering models of its SofPort Advanced Optics intraocular lenses (IOLs).

A single intravitreal injection of bevacizumab can aid short-term improvement in visual acuity (VA) and decrease optimal coherence tomography (OCT) retinal thickness in patients with uveitic cystoid macular oedema (CME), according to a recent study published in the March issue of Opthalmology.

Acuity Pharmaceuticals, Froptix and eXegenics have executed a merger agreement that will bring the three companies together as one, to be called Opko Corporation.

An increased level of white blood cells can predict the risk of developing early age-related macular degeneration (AMD), according to findings published recently in the American Journal of Epidemiology.

Tamarind seed polysaccharide (TSP) 0.5% and 1% offers at least equivalent relief from dry eye symptoms as hyaluronic acid (HA), according to a study published online by BMC Ophthalmology in March.

In persistent macular oedema, a single dexamethasone drug delivery system (DDS) treatment can significantly improve best corrected visual acuity (BCVA).

Pfizer has initiated the first in a series of planned clinical trials for PF-03187207, a new experimental medicine for the treatment of glaucoma.

Optometrists display a good ability to correctly identify and manage patients in busy accident and emergency (A&E) departments, according to a report published in the April issue of the British Journal of Ophthalmology.

pSivida has signed a $165 million collaborative research and licensing agreement with Pfizer for its controlled drug delivery technologies in ophthalmic applications.

Autologous platelet-rich plasma (PRP) is a very effective treatment for severe dry eye symptoms, according to the results of a study published in the March issue of Ophthalmic Research.

Relaxing incisions are a safe and effective method for reducing postoperative astigmatism and help improve visual acuity (VA), according to a study published in the March issue of the Journal of Refractive Surgery.

Laser suture lysis or releasable suture techniques can be a preferable alternative to permanent sutures for closing scleral flaps in primary trabeculectomy with mitomycin C (MMC) in uncomplicated glaucoma, according to a study published in the March issue of Journal of Glaucoma.

Intracameral phenylephrine is a straightforward and effective way to prevent the effects of floppy iris syndrome in patients taking systemic tamsulosin and undergoing cataract surgery.

The results of a questionnaire sent out to consultant ophthalmologists in the UK, has discovered that there is no one strategy in place for the management of glaucoma in pregnant women.

A new digital ophthalmoscope could provide optometrists with the ability to email detailed eye maps of patients to specialist eye doctors.

Bausch & Lomb is voluntarily recalling nine production lots of ReNu MultiPlus Multi-Purpose Solution.

The majority of patients with diabetic macular oedema (DME) who are given an injection of intravitreal triamcinolone (IVTA), will go on to develop cataract.

Daily oral administration of ruboxistaurin (RBX) may delay progression of diabetic macular oedema (DME) to a sight-threatening stage.

Anterior chamber intraocular lenses (IOLs) last twice as long as posterior chamber IOLs, before they need to be replaced.

The last few months have been particularly busy ones for me; we've reached April already and I really don't know where the first three months of 2007 have disappeared to. However, one thing that always gets me through particularly busy or stressful times is the great sense of achievement I feel when something is completed and also, a holiday, which I shall be spending this year with my husband in beautiful Italy.

Eyemaginations has been selected by Carl Zeiss Meditec to release two new patient education animations.

The annual cumulative cell loss in eyes implanted with toric iris-fixated phakic intraocular lenses (IOLs) is two to three times greater than in normal eyes without surgery, according to the results of a study published in the February issue of the Journal of Refractive Surgery.

A Phase I clinical study of Athenagen's topical eye drop therapy for wet age-related macular degeneration (AMD), ATG3, has found it to be safe and well tolerated.

Iridex has been granted a summary judgement, by the US District Court for the Eastern District of Missouri, on its against Synergetics.

Lux Biosciences has begun treating patients in a pivotal clinical trial programme of LX211.

Preliminary results from a Phase I trial of TargeGen's TG100801 eye drop for macular degeneration, has found it to be well tolerated in humans.

Nitric oxide-donating derivatives of latanoprost for the treatment of glaucoma have been shown to successfully lower intraocular pressure (IOP) in preclinical studies.

Tacrolimus is relatively safe and effective in reducing rejection and prolonging graft survival in subjects with high-risk keratoplasty.

Staar Surgical has revealed that its Visian toric implantable collamer lens (TICL) is unlikely to receive FDA approval in 2007.

SR Pharma has launched a Phase I clinical trial of RTP-801i.